Viridian Therapeutics is a biotech company specializing in treatments for rare diseases. Their pipeline includes VRDN-001 and VRDN-003 for thyroid eye disease, and VRDN-006 for autoimmune diseases. Founded in 2010, the company is based in Waltham, Massachusetts.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing